Title:Antihyperglycemic and Antidyslipidemic Effect of Moricandia Suffruticosa
in Normal and Streptozotocin-induced Diabetic Rats
Volume: 22
Issue: 1
Author(s): Amine Azzane, Ayoub Amssayef and Mohamed Eddouks*
Affiliation:
- Team of Ethnopharmacology & Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University
of Meknes, BP 509, Boutalamine, 52000. Errachidia. Morocco
Keywords:
Diabetes mellitus, antihyperglycemic, Moricandia suffruticosa, glycogen content, streptozotocin, diabetes.
Abstract:
Aims: The present work aimed to assess the antihyperglycemic and antihyperlipidemic
effects of Moricandia suffruticosa.
Background: Moricandia suffruticosa (M. suffruticosa) is used in traditional medicine.
Objective: The present study investigated the antihyperglycemic and antidyslipidemic effects of M.
suffruticosa and its effect on glycogen content in normoglycemic and hyperglycemic rats.
Methods: The effect of the aqueous extract of M. suffruticosa (AEMS) at two doses of 100 and 140
mg/kg on blood glucose levels, lipid, lipoprotein profile, and glycogen content was examined in
normal and streptozotocin (STZ)-induced diabetic rats. Moreover, preliminary phytochemical
screening and quantification of phenolic, flavonoid, and tannin contents were carried out.
Results: The results demonstrated that AEMS exhibits antihyperglycemic activity in diabetic rats
during both acute and subchronic assays. Furthermore, AEMS revealed an antidyslipidemic effect
concerning the level of triglycerides, total cholesterol, very-low-density lipoprotein (VLDL), and
non-high-density lipoproteins (Non-HDL). In contrast, AEMS has not affected the value of glycemia,
lipids, and lipoproteins in normal rats. In addition, AEMS is rich in several phytochemical
compounds. Furthermore, AEMS revealed an important in vitro antioxidant activity.
Conclusion: In conclusion, the study demonstrates that M. suffruticosa exhibits an important antihyperglycemic
effect in diabetic rats.